Key challenges for next-generation pharmacogenomics: Science & Society series on Science and Drugs

EMBO Reports

Volumn 15, Issue 5, 2014, Pages 472-476

  Kampourakis, Kostas ^a   Vayena, Effy ^b   Mitropoulou, Christina ^c   Van Schaik, Ron H ^c   Cooper, David N ^d   Borg, Joseph ^e   Patrinos, George P ^f  

^a UNIVERSITY OF GENEVA   (Switzerland)

^b UNIVERSITY OF ZURICH   (Switzerland)

^c ERASMUS MEDICAL CENTER   (Netherlands)

^d CARDIFF UNIVERSITY   (United Kingdom)

^e UNIVERSITY OF MALTA   (Malta)

^f UNIVERSITY OF PATRAS   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ACENOCOUMAROL; CLOPIDOGREL; DNA;

ARTICLE; CANCER SUSCEPTIBILITY; CLINICAL PRACTICE; COST; DECISION MAKING; DNA SEQUENCE; GENETIC VARIABILITY; HAPLOTYPE MAP; HEALTH CARE; HEALTH CARE PERSONNEL; HUMAN; INFORMED CONSENT; PERSONALIZED MEDICINE; PHARMACOGENOMICS; PRIORITY JOURNAL; SOCIAL JUSTICE; DRUG RESISTANCE; GENETICS; GENOMICS; PHARMACOGENETICS;

DRUG RESISTANCE; GENETIC VARIATION; GENOMICS; HUMANS; PHARMACOGENETICS; PRECISION MEDICINE;

EID: 84899884700     PISSN: 1469221X     EISSN: 14693178     Source Type: Journal    
DOI: 10.1002/embr.201438641     Document Type: Article

References (16)

1. Paré-Brunet L, Glubb D, Evans P, Berenguer-Llergo A, Etheridge AS, Skol AD, Di Rienzo A, Duan S, Gamazon ER, Innocenti F, (2014) Discovery and functional assessment of gene variants in the vascular endothelial growth factor pathway. Hum Mutat 35: 227-235
2. Vayena E, Matroianni A, Kahn J, (2012) Ethical issues in health research with novel online sources. Am J Public Health 12: 2225-2230
3. Vayena E, Prainsack B, (2013) Regulating genomics: time for a broader vision. Sci Transl Med 5: 198ed12
4. Whitley EA, Kanellopoulou N, Kaye J, (2012) Consent and research governance in biobanks: evidence from focus groups with medical researchers. Public Health Genomics 15: 232-242
5. Condit CM, (2010) Public understandings of genetics and health. Clin Genet 77: 1-9
6. Schweitzer NJ, Saks MJ, (2007) The CSI effect: popular fiction about forensic science affects the public's expectations about real forensic science. Jurimetrics 47: 357-364
7. Ley BL, Jankowski N, Brewer PR, (2012) Investigating CSI: portrayals of DNA testing on a forensic crime show and their potential effects. Public Underst Sci 21: 51-67
8. Retzbach J, Retzbach A, Maier M, Otto L, Rahnke M, (2013) Effects of repeated exposure to science TV shows on beliefs about scientific evidence and interest in science. J Media Psychol 25: 3-13
9. Castera J, Clement P, (2014) Teachers' conceptions about genetic determinism of human behaviour: a survey in 23 countries. Sci Edu 23: 417-443
10. Mills Shaw KR, van Horne K, Zhang H, Boughman J, (2008) Essay contest reveals misconceptions of high school students in genetics content. Genetics 178: 1157-1168
11. Stanek EJ, Sanders CL, Taber KA, Khalid M, Patel A, Verbrugge RR, Agatep BC, Aubert RE, Epstein RS, Frueh FW, (2012) Adoption of pharmacogenomic testing by US physicians: results of a nationwide survey. Clin Pharmacol Ther 91: 450-458
12. Haga SB, O'Daniel JM, Tindall GM, Mills R, Lipkus IM, Agans R, (2012) Survey of genetic counselors and clinical geneticists' use and attitudes toward pharmacogenetic testing. Clin Genet 82: 115-120
13. Mai Y, Mitropoulou C, Papadopoulou XE, Vozikis A, Cooper DN, van Schaik RH, Patrinos GP, (2014) Critical appraisal of the views of healthcare professionals with respect to pharmacogenomics and personalized medicine in Greece. Per Med 11: 15-26
14. Haga S, Burke W, Ginsburg G, Mills R, Agans R, (2012) Primary care physicians' knowledge and experience with pharmacogenomics testing. Clin Genet 82: 388-394
15. Caulfield T, (2012) DTC genetic testing: pendulum swings and policy paradoxes. Clin Genet 81: 4-6
16. Fleck LM, (2012) Pharmacogenomics and personalized medicine: wicked problems, ragged edges and ethical precipices. Nat Biotechnol 29: 757-768